Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 August 2024 | Story Martinette Brits | Photo Supplied
Dr Luther van der Mescht
Dr Luther van der Mescht, Senior Lecturer in the Department of Zoology and Entomology.

Ticks that feed on South Africa’s cattle are developing resistance to the only effective pesticides, making them increasingly difficult to control. If this issue is not addressed, the spread of these parasites and their resistance to pesticides could significantly impact farmers' incomes and food security.

According to a study by Dr Luther van der Mescht, Senior Lecturer in the Department of Zoology and Entomology, many tick populations in South Africa are resistant to at least two of the three main types of acaricides (chemical classes) used in the country.

Dr Van der Mescht notes that with around 12 million cattle in South Africa, these ticks not only lower meat and milk production but also carry pathogens that can cause potentially fatal diseases. He estimates that the economic losses from tick-borne diseases and the use of acaricides could reach up to R670 million annually in the cattle industry alone.

He adds that South Africa's agricultural sector is unique due to its dual farming system, which includes both subsistence and commercial farmers, amplifying the impact of ticks. “The country is also home to a wide variety of tick species that transmit numerous pathogens across a diverse range of habitats and climates in which cattle are farmed. Consequently, the effects of ticks and tick-borne diseases in South Africa may be more severe compared to those in developed countries.”

Dr Van der Mescht highlights that ticks are developing resistance primarily due to poor farm management practices, such as underdosing, overdosing, and excessive use of acaricides. “Additionally, insufficient government support in educating farmers and managing resistance exacerbates the problem.”

Managing acaricide resistance

Dr Van der Mescht explains that while ticks will inevitably develop resistance to acaricides, this usually happens much slower if pesticides are used strategically. To slow the development of resistance, several measures can be implemented: 

• Minimise the number of acaricide treatments.
• Assess tick diversity and acaricide resistance at the farm level and monitor it regularly. The study found that acaricide resistance was highly variable across South Africa, likely due to different farm management practices; hence it should be assessed at the farm level.
• Quarantine animals when transferring them to a new farm, ensuring they are free of ticks before releasing them.
• Rotate acaricides from different chemical classes, with a gap of at least two years between applications.

• Government veterinary services should raise awareness about acaricide resistance and provide support, particularly to under-resourced farmers. Establishing acaricide resistance testing laboratories would help monitor resistance and offer guidance to farmers.

Expert in parasitology

Dr Van der Mescht is particularly fascinated by the fact that most animals on earth follow a parasitic way of life. He graduated with a PhD in Conservation Ecology from the Department of Conservation Ecology and Entomology at Stellenbosch University in 2015, focusing on rodent parasites.

Career highlights include receiving the Wilhelm Neitz Memorial Scholarship in Parasitology from the Parasitological Society of Southern Africa (PARSA) for study abroad, and the Blaustein Centre for Scientific Cooperation Postdoctoral Fellowship in 2016 from Ben-Gurion University of the Negev, Israel, to conduct research on the experimental evolution of host specialisation. He also received the Claude Leon Foundation Postdoctoral Fellowship in 2019 to study the cat flea at Stellenbosch University’s Department of Botany and Zoology.

With over four years of experience in the industry at a contract research organisation, he has conducted more than 40 clinical studies for international pharmaceutical companies and published over 50 peer-reviewed scientific articles.

Making research visible, impactful, and relevant to society

Dr Van der Mescht recently published an article for The Conversation and participated in interviews with eNCA, Newzroom Afrika, and Cape Talk to discuss his research. “This effort aligns with the Vision 130 strategy of being a regionally engaged university and supports one of the key pillars of research development at the University of the Free State (UFS), which is to make our research visible, impactful, and relevant to society.”

He also highlighted the significance of popular science, noting that it helps scientists communicate their research to a broader audience, build their professional reputation, enhance their funding opportunities, and improve their research outcomes.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept